This Life Sciences Securities Litigation blog is Ropes & Gray’s resource for the latest news, analysis, and thought leadership regarding securities class action litigation in the life sciences space.
Ropes & Gray has extensive experience defending issuers in the life sciences space, including commercial-stage and clinical-stage pharmaceutical and biotech companies, as well as their officers, directors, and underwriters, in securities class action litigation across the country.
For more information and to explore our practice, visit our Corporate & Securities Litigation web page.